Drug Shortage Report for NAROPIN
| Report ID | 133713 |
| Drug Identification Number | 02229411 |
| Brand name | NAROPIN |
| Common or Proper name | Naropin® (ropivacaine HCl 2mg/mL 5x100mL SU Polybag®) |
| Company Name | ASPEN PHARMACARE CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | ROPIVACAINE HYDROCHLORIDE |
| Strength(s) | 2MG |
| Dosage form(s) | SOLUTION |
| Route of administration | EPIDURAL BLOCK/INFILTRATION BLOCK/INFILTRATION EPIDURAL |
| Packaging size | 5 PP Polybag |
| ATC code | N01BB |
| ATC description | ANESTHETICS, LOCAL |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2021-02-11 |
| Estimated end date | 2022-02-28 |
| Actual end date | 2022-02-28 |
| Shortage status | Resolved |
| Updated date | 2022-03-01 |
| Company comments | VR89890CA1 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | UNIT 8, 1155 NORTH SERVICE ROAD WEST OAKVILLE, ONTARIO CANADA L6M 3E3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2021-02-11 | English | Compare |
| v2 | 2021-02-11 | French | Compare |
| v3 | 2021-02-12 | English | Compare |
| v4 | 2021-09-03 | English | Compare |
| v5 | 2021-09-03 | French | Compare |
| v6 | 2021-09-14 | English | Compare |
| v7 | 2021-09-14 | French | Compare |
| v8 | 2021-09-28 | English | Compare |
| v9 | 2021-09-28 | French | Compare |
| v10 | 2021-10-14 | English | Compare |
| v11 | 2021-10-14 | French | Compare |
| v12 | 2022-02-07 | English | Compare |
| v13 | 2022-02-07 | French | Compare |
| v14 | 2022-02-10 | English | Compare |
| v15 | 2022-02-10 | French | Compare |
| v16 | 2022-02-10 | English | Compare |
| v17 | 2022-02-10 | French | Compare |
| v18 | 2022-02-23 | English | Compare |
| v19 | 2022-02-23 | French | Compare |
| v20 | 2022-02-28 | English | Compare |